Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Anticoagulation in COVID-19 with Elevated D-Dimer
NCT04377997Phase 2Unknown
- Sponsor
- Massachusetts General Hospital
- Start
- May 2020
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in coronavirus disease 2019 (COVID-19), sponsored by Massachusetts General Hospital. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04377997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377997.